Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011, 155(2):137-142 | DOI: 10.5507/bp.2011.026

RESTORATION OF ANGIOGENESIS BY ENALAPRIL IN DIABETIC HINDLIMB ISCHEMC RATS

Ali Reza Fallahzadeh, Majid Khazaei, Mohammad Reza Sharifi
Department of Physiology, Isfahan University of Medical Sciences, Isfahan, Iran

Background: Angiotensin-converting enzyme inhibitors have different effects on the cardiovascular system. The aim of this study was to investigate the effect of enalapril on skeletal muscle angiogenesis in diabetic and diabetic hind limb ischemic rats.

Methods: We studied 24 male diabetic rats (induced by streptozotocin, 55 mg/kg, ip) divided into four groups. Groups 1 and 2 were diabetic sham (surgical procedure without femoral artery ligation). Groups 3 and 4 were diabetic animals subjected to induced hind limb ischemia. Groups 2 and 4 received enalapril (15 mg/kg/day, i.p) and groups 1 and 3 received an equal volume of saline. After 21 days, capillary density, capillary to fiber (cap/fib) ratio and serum concentrations of nitric oxide (NO), Vascular Endothelial Growth Factor (VEGF) and soluble VEGF Receptor-1 (sVEGF-R1) were evaluated.

Results: Enalapril significantly increased serum NO and VEGF concentrations and reduced serum sVEGF-R1 concentrations in diabetic sham and hind limb ischemic rats (p<0.05). Administration of enalapril significantly increased capillary density and cap/fib ratio in diabetic sham and hind limb ischemic animals compared with nontreated groups (p<0.05).

Conclusions: Enalapril restores skeletal muscle angiogenesis in diabetic hind limb ischemia and can be considered for the prevention and treatment of peripheral artery disease in diabetic subjects.

Keywords: Diabetes, Hind limb ischemia, Capillary density, Enalapril, Rat

Received: October 27, 2010; Accepted: March 29, 2011; Published: June 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fallahzadeh, A.R., Khazaei, M., & Sharifi, M.R. (2011). RESTORATION OF ANGIOGENESIS BY ENALAPRIL IN DIABETIC HINDLIMB ISCHEMC RATS. Biomedical papers, 155(2), 137-142. doi: 10.5507/bp.2011.026
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ouriel K. Peripheral arterial disease. Lancet 2001;358:1257-64. Go to original source... Go to PubMed...
    2. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002;287:2570-81. Go to original source... Go to PubMed...
    3. Folkman J. Angiogenesis. Annu Rev Med 2006;57:1-18. Go to original source... Go to PubMed...
    4. Sheetz MJ, King GL. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 2002;288:2579- 88. Go to original source... Go to PubMed...
    5. Silvestre JS, Levy BI. Molecular basis of angiopathy in diabetes mellitus. Circ Res 2006;98:4-6. Go to original source... Go to PubMed...
    6. Weir MR. Effects of renin-angiotensin system inhibition on endorgan protection: can we do better? Clin Ther 2007;29:1803-24. Go to original source... Go to PubMed...
    7. Sasaki K, Murohara T, Ikeda H, Sugaya T, Shimada T, Shintani S, Imaizumi,T. Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis. J Clin Invest 2002;109:603-11. Go to original source... Go to PubMed...
    8. Li P, Kondo T, Numaguchi Y, Kobayashi K, Aoki M, Inoue N, Okumura K, Murohara T. Role of bradykinin, nitric oxide, and angiotensin II type 2 receptor in imidapril-induced angiogenesis. Hypertension 2008;51:252-58. Go to original source... Go to PubMed...
    9. Lloyd PG, Yang HT, Terjung RL. Arteriogenesis and angiogenesis in rat ischemic hindlimb: role of nitric oxide. Am J Physiol Heart Circ Physiol 2001;281:H2528-H2538. Go to original source... Go to PubMed...
    10. Taniyama Y, Morishita R, Hiraoka K, Aoki M, Nakagami H, Yamasaki K, Matsumoto K, Nakamura T, Kaneda Y, Ogihara T. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model: molecular mechanisms of delayed angiogenesis in diabetes. Circulation 2001;104:2344-50. Go to original source... Go to PubMed...
    11. Nematollahi S, Nematbakhsh M, Haghjooyjavanmard S, Khazaei M, Salehi M. Inducible nitric oxide synthase modulates angiogenesis in ischemic hindlimb of rat. Biomed Pap Med.Fac Univ Palacky Olomouc Czech Repub 2009;153:125-29. Go to original source... Go to PubMed...
    12. Baluchnejadmojarad T, Roghani M, Imani A. Protective effect of enalapril on vascular reactivity of the rat aorta. Vascul Pharmacol 2004;40:301-07. Go to original source... Go to PubMed...
    13. Khazaei M, Nematbakhsh M. The effect of hypertension on serum nitric oxide and vascular endothelial growth factor concentrations. A study in DOCA-Salt hypertensive ovariectomized rats. Regul Pept 2006;135:91-94. Go to original source... Go to PubMed...
    14. Nematbakhsh M, Ghadesi M, Hosseinbalam M, Khazaei M, Gharagozloo M, Dashti S, Rajabi P, Rafeian S. Oestrogen promotes coronary angiogenesis even under normoxic conditions. Basic Clin Pharmacol Toxicol 2008;103:273-77. Go to original source... Go to PubMed...
    15. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003;9:653-60. Go to original source... Go to PubMed...
    16. Simons M. Angiogenesis, arteriogenesis, and diabetes: paradigm reassessed? J Am Coll Cardiol 2005;46:835-37. Go to original source... Go to PubMed...
    17. Kivela R, Silvennoinen M, Lehti M, Jalava S, Vihko V, Kainulainen H. Exercise-induced expression of angiogenic growth factors in skeletal muscle and in capillaries of healthy and diabetic mice. Cardiovasc Diabetol 2008;7:13. Go to original source... Go to PubMed...
    18. Ebrahimian TG, Tamarat R, Clergue M, Duriez M, Levy BI, Silvestre JS. Dual effect of angiotensin-converting enzyme inhibition on angiogenesis in type 1 diabetic mice. Arterioscler Thromb Vasc Biol 2005;25:65-70. Go to original source... Go to PubMed...
    19. Gao L, Yu DM. Molecular mechanism of limbs' postischemic revascularization improved by perindopril in diabetic rats. Chin Med J (Engl.) 2008;121:2129-33. Go to original source... Go to PubMed...
    20. Chou E, Suzuma I, Way KJ, Opland D, Clermont AC, Naruse K, Suzuma K, Bowling NL, Vlahos CJ, Aiello LP, King GL. Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic States: a possible explanation for impaired collateral formation in cardiac tissue. Circulation 2002;105:373-79. Go to original source... Go to PubMed...
    21. Emanueli C, Graiani G, Salis MB, Gadau S, Desortes E, Madeddu P. Prophylactic gene therapy with human tissue kallikrein ameliorates limb ischemia recovery in type 1 diabetic mice. Diabetes 2004;53:1096-103. Go to original source... Go to PubMed...
    22. Hazarika S, Dokun AO, Li Y, Popel AS, Kontos CD, Annex BH. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1. Circ Res 2007;101:948-56. Go to original source... Go to PubMed...
    23. Li YJ, Guan H, Hazarika S, Liu CW, Annex BH. Impaired angiogenesis following hind-limb ischemia in diabetes mellitus mice. Chin Med Sci J 2007;22:232-37. Go to original source... Go to PubMed...
    24. Waltenberger J, Lange J, Kranz A. Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: A potential predictor for the individual capacity to develop collaterals. Circulation 2000;102:185-90. Go to original source... Go to PubMed...
    25. Roberts DM, Kearney JB, Johnson JH, Rosenberg MP, Kumar R, Bautch VL. The vascular endothelial growth factor (VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1 (VEGFR-2) signaling during blood vessel formation. Am J Pathol 2004;164:1531-35. Go to original source... Go to PubMed...
    26. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol 2006;7:359-71. Go to original source... Go to PubMed...
    27. Zheng Z, Chen H, Ke G, Fan Y, Zou H, Sun X, Gu Q, Xu X, HO PC. Protective effect of perindopril on diabetic retinopathy is associated with decreased vascular endothelial growth factor-to-pigment epithelium-derived factor ratio: involvement of a mitochondriareactive oxygen species pathway. Diabetes 2009;58:954-64. Go to original source... Go to PubMed...
    28. Christian JB, Lapane KL, Hume AL, Eaton CB, Weinstock MA. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial. J Natl Cancer Inst 2008;100:1223-32. Go to original source... Go to PubMed...
    29. Donnini S, Solito R, Giachetti A, Granger HJ, Ziche M, Morbidelli L. Fibroblast growth factor-2 mediates Angiotensin-converting enzyme inhibitor-induced angiogenesis in coronary endothelium. J Pharmacol Exp Ther 2006;319:515-22. Go to original source... Go to PubMed...

    Return to the content